The use of extracorporeal membrane oxygenation (ECMO) for critically-ill COVID-19 patient in clinical setting: A literature review

Authors

DOI:

https://doi.org/10.33448/rsd-v12i14.44589

Keywords:

COVID-19; Extracorporeal membrane oxygenation; Critical care; Complications; Operation.

Abstract

The use of ECMO may help sustain extracorporeal life support in cases where regular less-invasive modalities failed to adequately assist the body in maintaining basic life mechanisms. Typically, VV-ECMO is used in life-threatening respiratory failure. However, experts must consider relative contraindications, answering the question: ‘Will the patient really benefit from this treatment, or will it only add emotional and economic burden, also exposing the patient to various risks of complications?’. The physiology of oxygenation within the lungs, tissues, and ECMO machine, is a modification of the basic principles of respiratory physiology. In typical VV-ECMO cannula insertion, drainage cannula is inserted via the right femoral vein percutaneously and is guided upwards through inferior vena cava with its tip 10 cm below cavoatrial junction while the reinjection cannula will be inserted through the intrajugular vein. This places the artificial lungs in series with the normal lungs rather than in a parallel form. The artificially-oxygenated blood was then returned and mixed with the native venous blood. It is important to measure maximum drainage flow to prevent shunting of the veins by setting the ECMO to the highest flow. Frequent complications include co-infection up to sepsis and coagulopathy up to complications following it. Therefore, it is always beneficial to acquire multidisciplinary judgement, particularly with hematologists, intensivists, and infectious disease specialists prior, during, and post-ECMO use.

References

Beyls, C., Huette, P., Abou-Arab, O., Berna, P., & Mahjoub, Y. (2020). Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis. British Journal of Anaesthesia, 125(2), e260–e262. https://doi.org/10.1016/j.bja.2020.04.079

Bhagyalakshmi, V., Mbbs, N., & Melbourne, D. D. U. (2015). Extracorporeal Life Support Organization (ELSO) Ultrasound. https://www.elso.org/default.aspx

Calabrese, L. H., & Calabrese, C. (2020). Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1. Cleveland Clinic Journal of Medicine. https://doi.org/10.3949/ccjm.87a.ccc044

Channappanavar, R., Zhao, J., & Perlman, S. (2014). T cell-mediated immune response to respiratory coronaviruses. Immunologic Research, 59(1–3), 118–128. https://doi.org/10.1007/s12026-014-8534-z

Eckman, P. M., Katz, J. N., El Banayosy, A., Bohula, E. A., Sun, B., & Van Diepen, S. (2019). Veno-Arterial Extracorporeal Membrane Oxygenation for Cardiogenic Shock: An Introduction for the Busy Clinician. Circulation, 140(24), 2019–2037. https://doi.org/10.1161/CIRCULATIONAHA.119.034512

Extracorporeal Life Support Organization. (2022, October). ELSO International Summary of Statistics | ECMO | ECLS. https://www.elso.org/Registry/InternationalSummaryandReports/InternationalSummary.aspx

Fitzsimons, M. G., & Crowley, J. (2022). COVID-19: Extracorporeal membrane oxygenation (ECMO) - UpToDate (M. F. Connor, J. B. Mark, N. A. Nussmeier, & G. Finlay, Eds.). https://www.uptodate.com/contents/covid-19-extracorporeal-membrane-oxygenation-ecmo

Gattinoni, L., Vassalli, F., Romitti, F., Vasques, F., Pasticci, I., Duscio, E., & Quintel, M. (2019). Extracorporeal gas exchange: When to start and how to end? Critical Care, 23(1), 1–7. https://doi.org/10.1186/s13054-019-2437-2

Glebov, O. O. (2020). Understanding SARS-CoV-2 endocytosis for COVID-19 drug repurposing. FEBS Journal, 287(17), 3664–3671. https://doi.org/10.1111/febs.15369

Harnisch, L. O., & Moerer, O. (2021). Contraindications to the initiation of veno-venous ecmo for severe acute respiratory failure in adults: A systematic review and practical approach based on the current literature. Membranes, 11(8). https://doi.org/10.3390/membranes11080584

Kim, J. H., Pieri, M., Landoni, G., Scandroglio, A. M., Calabrò, M. G., Fominskiy, E., & Zangrillo, A. (2021). Venovenous ECMO treatment, outcomes, and complications in adults according to large case series: A systematic review. International Journal of Artificial Organs, 44(7), 481–488. https://doi.org/10.1177/0391398820975408

Makdisi, G., & Wang, I. W. (2015). Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology. Journal of Thoracic Disease, 7(7), E166–E176. https://doi.org/10.3978/j.issn.2072-1439.2015.07.17

Menni, C., Valdes, A. M., Polidori, L., Antonelli, M., Penamakuri, S., Nogal, A., & Spector, T. D. (2022). Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet (London, England), 399(10335), 1618–1624. https://doi.org/10.1016/S0140-6736(22)00327-0

Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., & Tian, D. S. (2020). Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases, 71(15), 762–768. https://doi.org/10.1093/cid/ciaa248

Ranieri, V. M., Rubenfeld, G. D., Thompson, B. T., Ferguson, N. D., Caldwell, E., Fan, E., & Slutsky, A. S. (2012). Acute respiratory distress syndrome: The Berlin definition. Jama, 307(23), 2526–2533. https://doi.org/10.1001/jama.2012.5669

Rozencwajg, S., Bréchot, N., Schmidt, M., Hékimian, G., Lebreton, G., Besset, S., & Luyt, C. E. (2018). Co-infection with influenza-associated acute respiratory distress syndrome requiring extracorporeal membrane oxygenation. International Journal of Antimicrobial Agents, 51(3), 427–433. https://doi.org/10.1016/j.ijantimicag.2017.11.005

Schmidt, M., Tachon, G., Devilliers, C., Muller, G., Hekimian, G., Bréchot, N., & Combes, A. (2013). Blood oxygenation and decarboxylation determinants during venovenous ECMO for respiratory failure in adults. Intensive Care Medicine, 39(5), 838–846. https://doi.org/10.1007/s00134-012-2785-8

Suteja, R., Novianti, P., Dewi, K., Widiyanti, E., Wijayanti, I., K, C., & Purnamasidhi, C. (2020). Migrant Workers of Indonesia: Transmission Channels of SARS-CoV-2 Amidst COVID-19 Pandemic in Indonesia. International Journal of Medical Reviews and Case Reports, 4(0), 1. https://doi.org/10.5455/ijmrcr.2020-05-197

Yang, S., Hua, M., Liu, X., Du, C., Pu, L., Xiang, P., & Liu, J. (2021). Bacterial and fungal co-infections among COVID-19 patients in intensive care unit. Microbes and Infection, 23(4–5), 104806. https://doi.org/10.1016/j.micinf.2021.104806

Yuki, K., Fujiogi, M., & Koutsogiannaki, S. (2020). COVID-19 pathophysiology: A review. Clinical Immunology, 215, 108427. https://doi.org/10.1016/j.clim.2020.108427

Yusuff, H., Zochios, V., & Brodie, D. (2020). Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation. ASAIO Journal, 66(8), 844–846. https://doi.org/10.1097/MAT.0000000000001208

Published

19/12/2023

How to Cite

PURNAMASIDHI, C. A. W.; SUTEJA, R. C.; UTAMA, I. M. S.; SOMIA, I. K. A.; MERATI, K. T. P.; ARYABIANTARA, I. W. The use of extracorporeal membrane oxygenation (ECMO) for critically-ill COVID-19 patient in clinical setting: A literature review . Research, Society and Development, [S. l.], v. 12, n. 14, p. e71121444589, 2023. DOI: 10.33448/rsd-v12i14.44589. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/44589. Acesso em: 19 nov. 2024.

Issue

Section

Health Sciences